In early 2025, researchers analyzing seized cannabis in Arizona revealed alarmingly high levels of toxic fungal contaminants in many of the samples. The findings reignited a long-standing concern across the cannabis industry: the persistent and often invisible threat of mycotoxins. These dangerous fungal metabolites continue to appear in cannabis flowers, extracts, edibles, and infused products—sometimes even after sterilization steps. As cannabis use grows for both recreational and medical purposes, especially among immunocompromised patients, mycotoxin safety has become one of the most urgent quality challenges facing the industry.
Mycotoxins are not new contaminants; they have plagued crops like corn, wheat, nuts, coffee, and spices for decades. But the unique properties of cannabis—its dense buds, moisture-retaining structure, curing processes, and consumer mode of use—make it uniquely vulnerable. Unlike food, cannabis is often inhaled, which dramatically increases toxic exposure because contaminants bypass digestion and enter the bloodstream directly through the lungs. Studies consistently show that even when microbial counts decrease through processes like gamma irradiation, the spores, biosynthetic genes, and toxins can persist. As a result, assessing, detecting, and preventing mycotoxin contamination requires far more than simple visual inspection or surface-level microbial testing.
What Are Mycotoxins?
Mycotoxins are small, biologically active molecules produced by certain fungi—most commonly Aspergillus, Penicillium, and Fusarium species. These compounds are secondary metabolites, meaning fungi do not need them for basic survival. Instead, they help fungi defend against viruses, UV light, environmental stress, and other microbial competitors. Unfortunately, when these metabolites enter the human body, they can cause severe health problems.
Hundreds of mycotoxins have been identified, and many are toxic, carcinogenic, nephrotoxic, or immunosuppressive. Crops like corn, wheat, apples, strawberries, coffee, and cannabis are especially susceptible. Because this danger is well-known in the food industry, many validated analytical techniques—such as LC-MS/MS and immunoaffinity chromatography—already exist and are now being applied to cannabis safety testing.
How Mycotoxins Develop in Cannabis
Mycotoxin contamination begins with the presence of fungal spores. These spores can be introduced during cultivation, drying, curing, processing, or storage. Once spores reach plant material and find favorable conditions—chiefly humidity, warmth, and poor airflow—they germinate and begin producing toxins.
Cultivation Risks
Cannabis plants can be infected in the soil, through contaminated tools, from neighboring crops, or even from airborne spores circulating in the grow space. High humidity strains, dense canopy structures, inadequate air circulation, and overwatering create perfect fungal incubators. Waterlogged substrates—such as poorly managed coco coir—are especially vulnerable to Aspergillus and Fusarium colonization.
Once growth begins, fungi may infect:
- Buds
- Leaves
- Stems
- Roots
Any infected tissue can accumulate mycotoxins, even if no visible mold appears.
Risks During Drying and Curing
Post-harvest handling is one of the most critical contamination windows. If buds dry too slowly or unevenly, moisture can remain trapped deep in the flower where mold develops out of sight. Long or poorly controlled curing processes can also enable fungal growth. Producers who process infected buds risk cross-contaminating entire product lines, especially when using shared grinders, trimmers, or extraction equipment.
Risks During Storage and Packaging
Temperature fluctuations and humidity swings inside storage rooms or packaging containers can reawaken dormant fungi, triggering new toxin production. This is why airtight, humidity-controlled packaging is essential.
Types of Mycotoxins in Cannabis
Aflatoxins (B1, B2, G1, G2)
Among the most dangerous, aflatoxins are produced by Aspergillus species in warm, humid environments. Aflatoxin B1 is one of the most carcinogenic organic compounds known. Symptoms of exposure can include liver damage, immune suppression, nausea, vomiting, convulsions, and in chronic cases, liver cancer.
Ochratoxin A (OTA)
Produced by Aspergillus and Penicillium, OTA is nephrotoxic and immunosuppressive. It is extremely stable and accumulates in the body over time. Symptoms range from fatigue and diarrhea to tremors and kidney dysfunction.
Fumonisins
More common in grain crops but capable of cross-contaminating cannabis. Poor sanitation or environmental transfer can introduce Fusarium species responsible for fumonisin production.
Zearalenone
Produced by Fusarium fungi, often thriving in high-humidity, unclean environments. Zearalenone has estrogenic effects and can disrupt hormonal systems.
Trichothecenes (T-2 toxin, deoxynivalenol/DON)
A highly toxic group produced by Fusarium, capable of causing severe inflammation, nausea, and immune dysfunction. These toxins can survive drying, curing, and even irradiation.
Citrinin
Produced by Penicillium and Monascus species, citrinin thrives in poor storage environments and can damage kidneys and the liver.
Health Risks of Mycotoxin Exposure
Unlike ingestion, inhalation delivers toxins directly into the respiratory system and bloodstream. Cannabis users face:
Acute Effects
- Nausea and vomiting
- Respiratory irritation or distress
- Coughing and shortness of breath
- Dizziness or tremors
Chronic Effects
- Liver cancer
- Chronic kidney disease
- Immune suppression
- Increased vulnerability to infections
- Hormonal disruption
Risks to Vulnerable Populations
The highest-risk groups include:
- Cancer patients
- Organ transplant recipients
- People undergoing chemotherapy
- HIV/AIDS patients
- Individuals with chronic respiratory conditions
Multiple clinical case reports link cannabis use to invasive aspergillosis—even in healthy users—making pristine microbial control essential.
Regulations and Testing Standards For Mycotoxins in Cannabis
Cannabis flower is not regulated as food in the United States. Instead, each state has its own mycotoxin limits, creating fragmented standards.
Typical Limits
Many states allow 20 μg/kg per toxin, but interpretations vary dramatically:
- Illinois: 20 μg/kg allowed per individual toxin (potentially up to 100 μg/kg total).
- California & Nevada: 20 μg/kg total aflatoxins + 20 μg/kg OTA (aligned with FDA food limits).
- New Mexico: 20 μg/kg combined limit for 5 regulated mycotoxins (Aflatoxin B1 (AFB1), Aflatoxin B2 (AFB2), Aflatoxin G1 (AFG1), Aflatoxin G2 (AFG2), and Ochratoxin A (OTA))—one of the strictest in the nation.
Despite these benchmarks, all regulatory limits are based on ingestion data, not inhalation, meaning real risks may be underestimated.
Modern Mycotoxin Testing Methods
Immunoaffinity Column Chromatography (ICC)
The gold-standard method for precise toxin quantification. Antibody-coated beads bind tightly to toxins while other plant materials wash away. A fluorescent dye then allows measurement down to 0.5 μg/kg.
LC-MS/MS
A highly sensitive technique that:
- Separates compounds via chromatography
- Identifies toxins by mass
- Detects multiple mycotoxins simultaneously
- Measures trace contamination with extreme accuracy
ELISA
Used to detect:
- Aflatoxins
- Ochratoxins
- DON
- T-2 toxins
Useful for screening large batches.
PCR / qPCR
Instead of detecting toxins, PCR identifies the genetic pathways responsible for toxin production. It can detect fungal presence before visible contamination occurs.
Testing Strips
Good for growers and consumers as an initial screen, but not a substitute for laboratory analysis.
Two types exist:
- Qualitative strips: yes/no detection
- Quantitative strips: approximate concentration, often requiring a reader
What Research Reveals About Persistence of Mycotoxins
A recent study examining gamma-irradiated cannabis buds showed that while irradiation reduced microbial loads, it did not fully remove:
- Viable Aspergillus, Fusarium, or Penicillium spores
- Biosynthetic mycotoxin genes
- Mycotoxins such as aflatoxins, OTA, DON, and T-2 toxins
DNA damage occurred, but toxins and spores persisted. This means:
- “Sterilized” cannabis may still contain harmful metabolites
- Standard microbial plate counts may underestimate risk
- Multifaceted testing is necessary to ensure safety
How a Cannabis LIMS Solution Strengthens Mycotoxin Testing
A Laboratory Information Management System (LIMS) is essential for managing the complexity of cannabis testing workflows. Here are key benefits that a lab can derive from a cannabis LIMS:
- Sample Tracking and Chain of Custody: A cannabis LIMS solution assigns unique barcodes and tracks samples from intake to disposal, ensuring traceability and preventing mix-ups.
- Instrument Integration: Direct integration with LC-MS/MS instruments allows seamless data transfer, eliminating transcription errors and ensuring data integrity.
- Automated QC and Calibration: LIMS systems monitor:
- Calibration schedules
- QC sample performance
- Instrument maintenance
This ensures consistent accuracy for mycotoxin detection.
- Document and SOP Management: Labs can maintain:
- SOP version control
- Staff training records
- Corrective action documentation
This helps demonstrate compliance during audits.
- Workflow Automation: From sample login to reporting, a cannabis LIMS standardizes processes, reducing turnaround time and minimizing human error.
- Certificate of Analysis (CoA) Generation: A LIMS helps generate CoAs with test results, action limits, methods used, analyst signatures, and batch details. The CoA can be shared with clients via LIMS’s secure client portal.
- Compliance with State Regulations: A modern cannabis LIMS solution includes:
- Configurable action limits
- State-specific testing panels
- Integrations with regulatory reporting systems such as METRC
This keeps the lab aligned with evolving cannabis regulations.
Conclusion
Mycotoxin contamination remains one of the most significant safety risks in the cannabis supply chain. Because mycotoxins persist even after mold is eliminated, accurate testing and strict quality controls are essential. By using robust analytical methods like LC-MS/MS and enforcing best practices from cultivation through processing, cannabis producers can significantly reduce contamination risks.
A cannabis LIMS solution enhances this process by improving sample tracking, instrument integration, QC oversight, documentation management, and regulatory compliance. As cannabis testing regulations continue to evolve, laboratories equipped with reliable LIMS infrastructure are better positioned to deliver safe, high-quality products that meet industry standards and protect consumer health.